Rhythm's Phase 3 trial shows setmelanotide significantly reduced BMI in rare hypothalamic obesity without new safety concerns over 52 weeks.
Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...
The most common surgical complications in obese patients with epithelial ovarian cancer (EOC) include wound infection, ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) suggests that ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) suggests that weight loss program targeting a particular % weight loss are often failing, ...
The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...
Gastric bypass is the most clinically and cost-effective form of interventional surgery for people living with severe obesity ...
For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results